(Q48180360)

9 February 2018

title

Autoantibodies against cardiac troponin I in patients with congestive heart failure (English)

1 reference

9 February 2018

0 references

1 reference

congestive heart failure

1 reference

Hans-Dirk Düngen

1

1 reference

9 February 2018

Maria Platzeck

2

1 reference

9 February 2018

Jörn Vollert

3

1 reference

9 February 2018

Julia Searle

4

1 reference

9 February 2018

Christian Müller

5

1 reference

9 February 2018

Janett Reiche

6

1 reference

9 February 2018

Felix Mehrhof

7

1 reference

9 February 2018

Reinhold Müller

8

1 reference

9 February 2018

Martin Möckel

9

1 reference

9 February 2018

publication date

31 May 2010

1 reference

9 February 2018

European Journal of Heart Failure

published in

1 reference

9 February 2018

volume

12

1 reference

9 February 2018

issue

7

1 reference

9 February 2018

page(s)

668-675

1 reference

9 February 2018

Clinical epidemiology of heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Coronary artery disease as the cause of incident heart failure in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Clinical trials update from the European Society of Cardiology Heart Failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Circulating cardiac troponin-I autoantibodies in human plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Cardiac troponin-I and risk of heart failure: a community-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ088

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ088

1 reference

9 February 2018

1 reference

9 February 2018